IP Library › Assignment 024024/0294
Patent Assignment
Reel/Frame 024024/0294

Change of Name

Recorded: 2010-03-03 Pages: 3
Assignor
HOLLIS-EDEN PHARMACEUTICALS, INC.
Executed: 2010-02-09
Assignee
HARBOR BIOSCIENCES, INC.
4435 EASTGATE MALL, SUITE 400, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (5)
Therapeutic treatment of androgen receptor driven conditions
Application: 09/675,323 →
Pharmaceutical Compositions
Patent: 7,776,845 →
Application: 11/835,334 →
Publication: US 2008/0021006
Formulations
Patent: 7,691,835 →
Application: 11/835,367 →
Publication: US 2008/0058301
Prostate and Breast Cancer Treatment
Patent: 7,696,189 →
Application: 11/835,394 →
Breast and Prostate Cancer Treatment Method
Patent: 7,863,261 →
Application: 11/835,397 →
Publication: US 2008/0176823
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 8, 2007
From: FRINCKE, JAMES M.; LARDY, HENRY; MARWAH, PADMA
To: HOLLIS-EDEN PHARMACEUTICALS, INC.
Reel/Frame 019667/0560 →
Assignment of Assignor's Interest Aug 10, 2007
From: FRINCKE, JAMES M; LARDY, HENRY; MARWAH, PADMA
To: HOLLIS-EDEN PHARMACEUTICALS, INC.
Reel/Frame 019681/0370 →
Assignment of Assignor's Interest Aug 10, 2007
From: FRINCKE, JAMES M; LARDY, HENRY; MARWAH, PADMA
To: HOLLIS-EDEN PHARMACEUTICALS, INC.
Reel/Frame 019681/0090 →
Change of Name Nov 2, 2012
From: HARBOR BIOSCIENCES, INC.
To: HARBOR DIVERSIFIED, INC.
Reel/Frame 029227/0929 →
Assignment of Assignor's Interest Feb 25, 2015
From: RESERVA LLC
To: NEURMEDIX, INC.
Reel/Frame 035030/0541 →
Assignment of Assignor's Interest Aug 8, 2021
From: NEURMEDIX, INC.
To: BIOVIE INC.
Reel/Frame 057116/0451 →
Assignment of Assignor's Interest Aug 8, 2021
From: NEURMEDIX, LLC
To: NEURMEDIX, INC.
Reel/Frame 057116/0362 →
Assignment of Assignor's Interest Aug 8, 2021
From: NEURMEDIX, INC.
To: NEURMEDIX, LLC
Reel/Frame 057116/0336 →